BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20438784)

  • 1. Pharmacology of putative selective hBRS-3 receptor agonists for human bombesin receptors (BnR): affinities, potencies and selectivity in multiple native and BnR transfected cells.
    Sancho V; Moody TW; Mantey SA; Di Florio A; Uehara H; Coy DH; Jensen RT
    Peptides; 2010 Aug; 31(8):1569-78. PubMed ID: 20438784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR; Weber HC; Hou W; Sainz E; Mantey SA; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1998 May; 273(22):13613-24. PubMed ID: 9593699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
    Moreno P; Mantey SA; Nuche-Berenguer B; Reitman ML; González N; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2013 Oct; 347(1):100-16. PubMed ID: 23892571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
    Mantey SA; Coy DH; Pradhan TK; Igarashi H; Rizo IM; Shen L; Hou W; Hocart SJ; Jensen RT
    J Biol Chem; 2001 Mar; 276(12):9219-29. PubMed ID: 11112777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
    Gonzalez N; Hocart SJ; Portal-Nuñez S; Mantey SA; Nakagawa T; Zudaire E; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2008 Feb; 324(2):463-74. PubMed ID: 18006692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
    Mantey SA; Weber HC; Sainz E; Akeson M; Ryan RR; Pradhan TK; Searles RP; Spindel ER; Battey JF; Coy DH; Jensen RT
    J Biol Chem; 1997 Oct; 272(41):26062-71. PubMed ID: 9325344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.
    Uehara H; González N; Sancho V; Mantey SA; Nuche-Berenguer B; Pradhan T; Coy DH; Jensen RT
    Peptides; 2011 Aug; 32(8):1685-99. PubMed ID: 21729729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
    Mantey SA; Coy DH; Entsuah LK; Jensen RT
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of bombesin receptor subtype-specific ligands: effect of N-methyl scanning, truncation, substitution, and evaluation of putative reported selective ligands.
    Mantey SA; Gonzalez N; Schumann M; Pradhan TK; Shen L; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 2006 Nov; 319(2):980-9. PubMed ID: 16943256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
    Weber D; Berger C; Heinrich T; Eickelmann P; Antel J; Kessler H
    J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Characterization of a Novel, High-Affinity, Specific, Radiolabeled Ligand for BRS-3 Receptors.
    Ramos-Alvarez I; Lee L; Mantey SA; Jensen RT
    J Pharmacol Exp Ther; 2019 Jun; 369(3):454-465. PubMed ID: 30971479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel chiral-diazepines function as specific, selective receptor agonists with variable coupling and species variability in human, mouse and rat BRS-3 receptor cells.
    Ramos-Álvarez I; Nakamura T; Mantey SA; Moreno P; Nuche-Berenguer B; Jensen RT
    Peptides; 2016 Jan; 75():8-17. PubMed ID: 26524625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
    Ryan RR; Weber HC; Mantey SA; Hou W; Hilburger ME; Pradhan TK; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 1998 Oct; 287(1):366-80. PubMed ID: 9765358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium.
    Amiot F; Leiber D; Marc S; Harbon S
    Am J Physiol; 1993 Dec; 265(6 Pt 1):C1579-87. PubMed ID: 8279518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A selective human bombesin receptor subtype-3 peptide agonist mediates CREB phosphorylation and transactivation.
    Qin X; Qu X; Coy D; Weber HC
    J Mol Neurosci; 2012 Jan; 46(1):88-99. PubMed ID: 22127929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a unique ligand which has high affinity for all four bombesin receptor subtypes.
    Pradhan TK; Katsuno T; Taylor JE; Kim SH; Ryan RR; Mantey SA; Donohue PJ; Weber HC; Sainz E; Battey JF; Coy DH; Jensen RT
    Eur J Pharmacol; 1998 Feb; 343(2-3):275-87. PubMed ID: 9570477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent and selective peptide agonists at the GRP-preferring bombesin receptor (BB2).
    Darker JG; Brough SJ; Heath J; Smart D
    J Pept Sci; 2001 Nov; 7(11):598-605. PubMed ID: 11763364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and functional characterization of hemorphins VV-H-7 and LVV-H-7 as low-affinity agonists for the orphan bombesin receptor subtype 3.
    Lammerich HP; Busmann A; Kutzleb C; Wendland M; Seiler P; Berger C; Eickelmann P; Meyer M; Forssmann WG; Maronde E
    Br J Pharmacol; 2003 Apr; 138(8):1431-40. PubMed ID: 12721098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM; Nitecki DE; Biancalana S; Feldman RI
    Mol Pharmacol; 1996 Nov; 50(5):1355-63. PubMed ID: 8913368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.